DPP4 and chronic myelogenous leukemia, BCR-ABL1 positive: First, we clearly demonstrated that 100% of CML patients at diagnosis show CML-specific CD26+ LSCs and that CD26+ LSCs absolute number is superimposable in PB and BM samples allowing us to easily quantify LSCs directly in PB.